This week the US Food and Drug Administration approved the release of fingolimod (trade name Gilenya®), the first oral medication for the treatment of remitting relapsing multiple sclerosis. Swedish Neuroscience Institute is proud to have participated in the pivotal clinical trial that led to the approval of Gilenya. Gilenya is a welcome addition to the set of medications available to patients living with MS. There are currently five injectable therapies and two intravenous therapies approved by the FDA for the treatment of MS. Although these treatments are very effective, many patients have been hoping for an oral alternative. Some patients are finding that they have “injection fatigue” or are running out of places to inject the medication. It is important to note, however, that not all patients should switch to Gilenya. Patients with stable disease should remain on their medications. Patients need to be informed of the risks associated with Gilenya, including slowed heart rate, increased blood pressure, difficulty breathing, abnormal liver function, and infection, and how these risks may apply to them. If you are wondering whether Gilenya is right for you, please ask your neurologist.
Most Recent Articles

Dawn Miller was debilitated by chronic pain. Swedish Pain Services helped her find relief and rediscover pleasure in the simple activities of daily life.

Learn what a reproductive health expert at Swedish has to say about polycystic ovary syndrome — a metabolic condition caused by a hormone imbalance.

A Swedish behavioral health expert explains this polyvagal technique targeting our parasympathetic nervous system, which is responsible for relaxing our body after a period of stress or danger.

Learn about the variety of options available for managing chronic pain at Swedish Pain Services.

Guadalupe Duarte has been a certified medical assistant at the Providence Swedish's Edmonds Birth and Family Clinic since 2020.

Learn about the current state of the addiction crisis in America and new tools to help with recovery, including treatments and peer support options.

Seattle’s KING 5 TV hosted a panel of sought-after Swedish specialists for a conversation about advanced treatments at Swedish and why patients from around the world choose us for their care.

Hay tres vacunas disponibles para ayudar a prevenir la gripe, el COVID y el virus respiratorio sincitial (respiratory syncytial virus, RSV) este otoño. Descubra cuáles son recomendables para usted.

Midfielder Albert Rusnák spent time with caregivers and discussed the importance of caring for physical and mental health.

More than 140 physicians, physician assistants and nurse practitioners recognized in the annual survey.

Dr. Peter Olson lost a beloved cousin to suicide. On Nov. 5, he’s running the NYC Marathon to raise money for suicide prevention and survivor support.

A Swedish behavioral health expert offers some guidance to help ourselves or a loved one.

Running can be a great way to improve your health in body, mind and spirit. Find out how to train safely and reach your most ambitious running goals.

Swedish experts provide perspective on the research and share advice for staying healthy and preventing cancer.

There are three vaccines available to help prevent the flu, COVID and respiratory syncytial virus (RSV) this fall. Find out which are recommended for you.

A Swedish behavioral health expert explains how spending time in nature supports our mental and physical well-being.

Learn what you need to know about prostate cancer — and about new tools for diagnosing and treating the disease.

El equipo viaja por toda el área de Puget Sound para ofrecer exámenes de salud y fomentar las conexiones comunitarias.

A Swedish respiratory therapist offers tips to help us avoid the flu and protect ourselves and our families.

Occupational Therapist Simon Gale, the program's leader, on New Day Northwest. Share the thrill of skydiving with a program participant.